Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso

NCT06652737 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria Falciparum
Malaria Infection

Interventions

BIOLOGICAL: PfSPZ-LARC2 Vaccine
BIOLOGICAL: Normal Saline (Placebo)

Sponsor

Sanaria Inc.

Collaborators

[object Object]
[object Object]
[object Object]